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 The variant p.Tyr473Cys in the ACTN2 gene, coding
for the Z-disk protein alpha-actinin-2, leads to a
dominantly inherited phenotype suggestive of left-
dominant arrhythmogenic cardiomyopathy (ACM).
This implies that analysis of ACTN2 might be
considered in patients with ACM in whom genetic
screening was inconclusive.
 The signal for plakoglobin was markedly reduced in
the myocardial biopsy of our index case. This
further supports the concept that plakoglobin
deﬁciency may be a common feature of ACMs,
independently of their molecular origin.
 The decreased signal for plakoglobin in the
myocardial biopsy of our index case suggests a link
between Z-disc proteins and the desmosome. This
remains to be investigated.Introduction
Arrhythmogenic cardiomyopathy (ACM) is a heritable heart
disease characterized by ﬁbrofatty replacement of the cardio-
myocytes. It can result in life-threatening arrhythmias and
sudden cardiac death (SCD). Arrhythmogenic right ventricu-
lar dysplasia/cardiomyopathy (ARVD/C) is the most com-
mon form of ACM, while left-dominant or biventricular
ACM is less frequent.1 Genes involved in ACM pathology
mainly encode desmosomal protein,2 but anomalies in other
genes have been described.3,4
Variants in the alpha-actinin-2 (ACTN2) gene have been
associated with different cardiac manifestations, including
hypertrophic cardiomyopathy (HCM), dilated cardiomyopa-
thy (DCM),5–9 atrial arrhythmia,6 left ventricular noncom-
paction (LVNC), idiopathic ventricular ﬁbrillation, and
SCD.7 Alpha-actinin-2, the protein encoded by ACTN2, is
a major component of the sarcomere Z-disc expressed in
the cardiac and skeletal muscle. Its supposed role is to bind
actin ﬁlaments and to stabilize the muscle contractile appa-
ratus.10,11 Changes in its scaffolding function have been pro-
posed to be pathogenic and lead to DCM and HCM.
Additionally, alpha-actinin-2 interacts with several signaling
proteins and ion channels.11,12 Some speculate that mutant
alpha-actinin-2 affects the localization and function of car-
diac ion channels and thus might contribute to arrhythmic
phenotypes. We describe here 4 members of a Swiss family
in which a missense ACTN2 variant cosegregates with a car-
diomyopathy suggestive of left-dominant ACM.KEYWORDS ACTN2; Alpha-actinin-2; Arrhythmia; Left-dominant
arrhythmogenic cardiomyopathy; Next-generation sequencing; Plakoglobin
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The female proband (II-2 in Figure 1B) presented with poly-
morphic ventricular premature beats at age 25 years. At age
62, she experienced tiredness, dyspnea, and thoracic discom-
fort. The electrocardiogram revealed low voltage in periph-
eral leads and T-wave inversion in lead V5 and V6
(Figure 2A). Coronary angiography showed no evidence of
coronary artery disease. The cardiovascular magnetic reso-
nance demonstrated a diffusely hypokinetic nondilated left
ventricle with a reduced ejection fraction (41%) and wide-
spread areas of late gadolinium enhancement predominantly
in the inferior and anterolateral walls (Figure 2B). The right
ventricle was considered normal. A metabolic positron emis-
sion tomography scan did not reveal any inﬂammatoryen access article
.0/).
https://doi.org/10.1016/j.hrcr.2019.10.001
Figure 1 Genetic investigations.A: Sanger sequence conﬁrmation of the ACTN2 variant c.1418A.G (p.Tyr473Cys). B: Family pedigree. Lines through sym-
bols indicate deceased subject; arrow indicates proband; red symbols indicate heterozygous carriers of p.Tyr473Cys in ACTN2 and affected by left-dominant
arrhythmogenic cardiomyopathy.
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biopsy showed diffuse ﬁbrosis without fatty replacement
(Figure 3A). Immunoﬂuorescence staining revealed a mark-
edly diminished signal for plakoglobin (Figure 3B), while the
signal level was preserved for other desmosomal proteins.
The diagnosis of left-dominant ACM was strongly suspected
based on the ventricular arrhythmias, T-wave inversions in
the precordial leads, diffuse hypokinesia with late gadolin-
ium enhancement, and the diffuse areas of ﬁbrosis. Following
some episodes of symptomatic nonsustained ventricular
tachycardia, a cardioverter-deﬁbrillator was implanted.
The offspring (III-1, III-2, III-3; Figure 1B) of the proband
(II-2), aged 44, 36, and 35 years, respectively, all presented
with right bundle branch block morphology ventricular pre-
mature beats. They reported fatigue, dyspnea, and/or palpita-
tions. Their electrocardiograms were all characterized by low
voltages in peripheral leads, T-wave inversion in lateral leads
(III-1), incomplete right bundle branch block (III-3), and
otherwise normal traces (III-2). Cardiovascular magnetic
resonance was suggestive of a left-dominant ACM in all 3.
The ejection fractions were reduced in III-1 (ventricle left:
47%, right: 49%) and preserved in III-2 and III-3. Areas of
late gadolinium enhancement restricted to the left ventricle
were observed with a predominance for the subepicardial
layer of the heart basal regions in the anteroseptal, anterolat-
eral, inferior, and inferoseptal walls (III-1); anteroseptal, infe-
rior, and inferoseptal walls (III-2); and anterior, anteroseptal,
and anterolateral walls (III-3).
Given the familial nature of the cardiomyopathy, high-
throughput DNA sequencing (using TruSight One panel
from Illumina, San Diego, CA) was performed to screen 10
genes (ACTN2, DSG2, DSC2, PKP2, DSP, LDB3, JUP,
RYR2, TGFb3, TMEM43) involved in arrhythmogenic and
related cardiomyopathies. In the proband (II-2) and in the 3
children (III-1, III-2, III-3), the ACTN2 missense variantc.1418A.G, p.Tyr473Cys was identiﬁed in heterozygosity
(Figure 1A). No variants were found in the other genes of
the panel, notably in JUP, encoding plakoglobin. For the rea-
sons explained in the discussion section (below), the variant
p.Tyr473Cys in ACTN2 was considered likely pathogenic
and causative of the familial left-dominant ACM.Discussion
Several ACTN2 mutations located in different regions of the
protein, including the actin binding, spectrin-like, and
calmodulin-like domains, have been associated to HCM.5,6,8
Among them, the p.Thr495Met variant, located in the second
spectrin-like domain similarly as p.Tyr473Cys, was observed
in 3 different families.5,8 The spectrin-like domain of alpha-
actinin-2 is known to interact with different structural and
signaling proteins.11 Less frequently, ACTN2 mutations have
been associated with the phenotype of DCM, as for example
in carriers of the p.Gln9Arg variant.9 In addition, members
of 2 families with variants in the actin binding domain of
alpha-actinin-2 presented with a more complex and heteroge-
nous cardiac phenotype: the p.Ala119Thr variant was linked
to DCM, LVNC, idiopathic ventricular ﬁbrillation, and
SCD,7 and the p.Met228Thr variant cosegregated with
HCM, early-onset supraventricular arrhythmias, and atrioven-
tricular block, as well as with LVNC.6 Finally, an association
between ACTN2 and ARVD/C has already been reported in
the ClinVar database (unpublished; p.Glu829Ter,
SCV000740535). In summary, heterozygous missense muta-
tions of ACTN2 are associated with a range of cardiac pheno-
types, including structural and rhythmic disorders with a
highly variable expressivity, even for a given variant.
The variant p.Tyr473Cys has been recently reported
in association with a phenotype of DCM/HCM but was
considered of “uncertain signiﬁcance” owing to insufﬁcient
Figure 2 Cardiologic investigations in subject II-2. A: Electrocardiogram showing low voltage in peripheral leads and T-wave inversion in lead V5 and V6.
B:Magnetic resonance imaging showing late gadolinium enhancement. C:Metabolic positron emission tomography scan showing no inﬂammatory component.
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reported in the ClinVar database, SCV000834859). Howev-
er, several arguments suggest a pathogenic role. First,
p.Tyr473Cys segregates with the phenotype of left-
dominant ACM in 4 members of our family. Second, the
Tyr473 residue is highly conserved across various species,
and its replacement with cysteine is estimated as deleterious
by the prediction programs PolyPhen-2 and SIFT. Finally,this amino acid substitution has not been observed in the pub-
lic database gnomAD as of April 2019. For these reasons, we
consider p.Tyr473Cys as likely pathogenic even in the
absence of direct functional proof.
The phenotype in affected members of our family is
homogenous and corresponds well with left-dominant ACM
as described by Sen-Chowdhry and colleagues1: ventricular
arrhythmia of right bundle block conﬁguration (ie, arising
Figure 3 Left ventricle endomyocardial biopsy from subject II-2. A: Microscopic appearance showing diffuse ﬁbrosis. B: Immunoﬂuorescence microscopy
showing a diminished signal for plakoglobin in subject II-2 (left) and a normal signal in a control (right).
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leads, mild left ventricular dilation and/or systolic impairment,
myocyte loss with ﬁbrofatty or ﬁbrotic replacement conﬁrmed
by biopsy, or late gadolinium enhancement in the left ventricle
on cardiac magnetic resonance.While left-dominant ACMhas
not been associated with ACTN2 mutations so far, DCM,
which is part of the phenotypic spectrum of ACTN2-related
disease, shares common features with left-dominant ACM.
The distinction between these 2 entities is mainly based on
the degree of ventricular arrhythmias compared to the extent
of morphologic abnormalities.1 It is hence not surprising to
ﬁnd a common genetic cause for these 2 pathologies, and
we cannot exclude that the subjects of this study will develop
some signs of DCM in the future. The exact mechanism by
which the substitution of a tyrosine by a cysteine residue in
position 473 could lead to an ACM remains to be determined.
The double function of alpha-actinin-2 as a scaffold as well as
an interactor with signaling proteins and ion channels11,12
might explain why its dysfunction leads to a phenotype (ie,
ACM) in which both structural remodeling of cardiac muscle
and ventricular arrhythmias are present. While ACMs are
mainly caused by variants in desmosomal genes, left-dominant
forms have often been related to anomalies of other genes.3,4Interestingly, at least 2 of these genes, DES and FLNC,
encode Z-disc-related proteins (desmin and ﬁlamin C).3,4
Thus, it is tempting to speculate that a primary disruption
of the sarcomeric Z-disc can be, at least in some cases, central
to the pathogenesis of left-dominant ACM.
Interestingly, immunohistology of the endomyocardial bi-
opsy in the proband revealed a markedly diminished signal
for plakoglobin, one of the desmosomal proteins. Asimaki
and colleagues13 have already observed a decreased plako-
globin signal in ARVD/C. In our family, in which ACM
appears to be caused by the nondesmosomal gene ACTN2,
the observation of reduced plakoglobin signal was unex-
pected (of note, the plakoglobin and other desmosomal pro-
tein genes were normal). In this regard, our report further
supports the concept that a reduced plakoglobin signal is
characteristic of all ACMs independently of their origin
and is not only the consequence of a primary alteration of
desmosomal complex. Furthermore, our observations sug-
gest that the decrease in plakoglobin signal is not speciﬁc
for ARVD/C but also characterizes left-dominant ACM.
The concept of common ﬁnal pathway expresses the idea
that the disruption of certain genes or proteins sharing a com-
mon function is central to the pathogenesis of a given
Good et al ACTN2 Variant and Arrhythmogenic Cardiomyopathy 19cardiogenetic disease with a speciﬁc phenotype (for example,
the alteration of sarcomere proteins in HCM).14 Our ﬁnding
that plakoglobin was reduced without causative desmosomal
gene abnormality supports the concept of a common ﬁnal
pathway and the hypothesis that ACMs are desmosomopa-
thies. Although no direct interaction is known so far, it is
tempting to speculate that alpha-actinin-2 might somehow
interact with desmosomal proteins. Such an interaction might
be mediated by desmin, a component of intermediate ﬁla-
ments that connects the Z-disc complex to desmosomes.15Conclusion
Clinical investigations of a family with a phenotype compat-
ible with a left-dominant ACM led to the identiﬁcation of a
likely pathogenic ACTN2 variant. This ﬁnding further ex-
pands the spectrum of human diseases linked with ACTN2.
The description of a similar association in other families
would help to conﬁrm this hypothesis. Our report also sug-
gests that a primary dysfunction of Z-disc could be central
to the pathogenesis of left-dominant ACM. On the other
hand, the decreased signal for plakoglobin in the myocardial
biopsy of our index case supports the existence of a close link
between Z-disc and desmosome. For the clinical practice, this
suggests that ACTN2 variant screening might be considered
in patients with ACM in whom ACM gene panel testing
was negative.Acknowledgments
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